多支动脉桥在非体外与体外循环冠脉搭桥中的影响
该单中心长期倾向性评分分析纳入5195例单支动脉ONCAB、1208例多支动脉ONCAB、4412例单支动脉OPCAB和1818例多支动脉OPCAB,比较四组长期生存。中位随访8.2±4.7年,多支动脉OPCAB和多支动脉ONCAB均与较低的晚期死亡率相关(HR均为0.81)。
要点
- 多支动脉OPCAB与常规ONCAB安全性相当,长期生存优于单支动脉ONCAB。
- 多支动脉OPCAB的晚期死亡率低于单支动脉ONCAB(HR 0.81,95%CI 0.69-0.98)。
- 多支动脉ONCAB的晚期死亡率也低于单支动脉ONCAB(HR 0.81,95%CI 0.65-0.99)。
核心结论
- 多支动脉OPCAB与常规ONCAB同样安全,长期生存率优于单支动脉ONCAB,与多支动脉ONCAB相当。
研究设计与样本
- 单中心长期倾向性评分分析,纳入5195例SA-ONCAB、1208例MA-ONCAB、4412例SA-OPCAB和1818例MA-OPCAB,全部病例有晚期生存数据。
主要发现
- 四组30天死亡率、术后脑血管意外和肾脏替代治疗无显著差异。
- 平均随访8.2±4.7年,倾向性评分加权后10年生存率分别为SA-ONCAB 74.5±0.4%、MA-ONCAB 79.7±0.4%、SA-OPCAB 73.4±0.5%、MA-OPCAB 79.0±0.5%。
- 倾向性加权分析显示,MA-OPCAB(HR 0.81,95%CI 0.69-0.98)和MA-ONCAB(HR 0.81,95%CI 0.65-0.99)与较低的晚期死亡率相关,对照为标准SA-ONCAB。
临床怎么用
- 在多支动脉桥可行时,OPCAB可达到与ONCAB相当的长期生存,且优于单支动脉ONCAB。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: There is growing concern that off-pump coronary artery bypass (OPCAB) is associated with reduced long-term survival compared with traditional on-pump coronary artery bypass (ONCAB); however, most of available comparisons between OPCAB and ONCAB focus on single-artery (SA) revascularization. We sought to investigate the impact of using multiple arterial (MA) conduits in the comparison between OPCAB versus ONCAB by performing a single-center, long-term propensity score base analysis. METHODS: The study population included 5195 SA-ONCAB, 1208 MA-ONCAB, 4412 SA-OPCAB, and 1818 MA-OPCAB procedures. Late survival was available for all cases (100%). Inverse propensity score weighting and a time-segmented Cox model were used for multiple treatments comparison. RESULTS: No significant differences were found between the 4 groups in terms of 30-day mortality, postoperative cerebrovascular accident, and renal replacement therapy. After a mean follow-up time of 8.2 ± 4.7 years, in the propensity score-weighted sample, survival probabilities at 10 years were 74.5 ± 0.4, 79.7 ± 0.4, 73.4 ± 0.5, and 79.0 ± 0.5 in the SA-ONCAB, MA-ONCAB, SA-OPCAB, and MA-OPCAB groups respectively. Propensity-weighted analysis confirmed that MA-OPCAB (hazard ratio, 0.81; 95% confidence interval, 0.69-0.98) and MA-ONCAB (hazard ratio, 0.81; 95% confidence interval, 0.65-0.99) were associated with a lower late mortality compared with standard SA-ONCAB. CONCLUSIONS: OPCAB with multiple arterial grafts is as safe as the conventional ONCAB and achieves excellent long term survival rates which are superior to those observed after standard SA-ONCAB and comparable with MA-ONCAB.
引用
- Benedetto U, Caputo M, Mariscalco G, et al. Impact of multiple arterial grafts in off-pump and on-pump coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2016. PMID: 27955911. doi:10.1016/j.jtcvs.2016.10.084
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。